Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The Novo Nordisk Foundation Center for Protein Research is supported financially by the Novo Nordisk Foundation (grant number NNF14CC0001)
J Clin Endocrinol Metab 88:46964701 Santoprete A, Capito E, Carrington PE et al (2011) DPP-IV-resistant, long-acting oxyntomodulin derivatives
It has been approved as a second line treatment option for better glycaemic control in type 2 diabetes and currently under scrutiny for anti-obesity purpose
In the l-carnitine group, the NIRS data at 8 weeks treatment was significantly improved as compared to the baseline (0.096 0.058 vs
J Psychoactive Drugs 2011;43(1):1-5
US$ 26.95
US$ 25.63
US$ 24.49
US$ 26.78
US$ 27.06
US$ 21.43
US$ 20.67
US$ 28.77
US$ 26.78
US$ 23.46
